Related references
Note: Only part of the references are listed.Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer
Miles A. Miller et al.
CLINICAL CANCER RESEARCH (2017)
Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
Jesus I. Luna et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice
Lunmei Tan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
Anna Karolina Kozlowska et al.
JOURNAL OF CANCER (2017)
Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27
Norberto Walter Zwirner et al.
FRONTIERS IN IMMUNOLOGY (2017)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment
Mingyue Li et al.
ONCOLOGY REPORTS (2016)
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality
Antonella Mancusi et al.
BLOOD (2015)
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Luis Martinez-Lostao et al.
CLINICAL CANCER RESEARCH (2015)
Potentiation of cytokine-induced proliferation of human Natural Killer cells by intravenous immunoglobulin G
Andrew C. Issekutz et al.
CLINICAL IMMUNOLOGY (2015)
Improving natural killer cell cancer immunotherapy
Melissa M. Berrien-Elliott et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2015)
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
Katayoun Rezvani et al.
FRONTIERS IN IMMUNOLOGY (2015)
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wei Wang et al.
FRONTIERS IN IMMUNOLOGY (2015)
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
Carin I. M. Dahlberg et al.
FRONTIERS IN IMMUNOLOGY (2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
Jianfeng Han et al.
SCIENTIFIC REPORTS (2015)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
Jeffrey W. Leong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
Veronika Bachanova et al.
BLOOD (2014)
Natural killer cells as effectors of selection and differentiation of stem cells: Role in resolution of inflammation
Anahid Jewett et al.
JOURNAL OF IMMUNOTOXICOLOGY (2014)
Efficient generation of human natural killer cell lines by viral transformation
B. Vogel et al.
LEUKEMIA (2014)
Diphtheria toxin-based recombinant murine IL-2 fusion toxin for depleting murine regulatory T cells in vivo
Min Wei et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy
Q. Zhou et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Andres Wiernik et al.
CLINICAL CANCER RESEARCH (2013)
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
Branka Petricevic et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Combination immune therapies to enhance anti-tumor responses by NK cells
Ashley Mentlik James et al.
FRONTIERS IN IMMUNOLOGY (2013)
Immuno-oncology: understanding the function and dysfunction of the immune system in cancer
O. J. Finn
ANNALS OF ONCOLOGY (2012)
NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma
M. Watanabe et al.
DISEASES OF THE ESOPHAGUS (2010)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Mark Shackleton et al.
CELL (2009)
Looking ahead in cancer stem cell research
John E. Dick
NATURE BIOTECHNOLOGY (2009)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
A Diefenbach et al.
NATURE IMMUNOLOGY (2000)
Share Paper
